The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest from CDMOs, CMOs, and suppliers featuring PerkinElmer, Resilience, Grifols, WuXi Biologics, Catalent, and SCA Pharma.
Biologics Manufacturing
Resilience To Acquire Cell-Therapy Mfg Facility from bluebird bio Resilience, a recently...
Cytiva, the new name of GE Healthcare Life Sciences following Danaher’s $21.4-billion acquisition of GE Healthcare Life Sciences in 2020, and Pall Corporation, a provider of filtration, separation, and purification products and services and part of...
The latest from CDMOs, CMOs, and suppliers featuring Recipharm, Vetter, Dipharma, Archimica, DFE Pharma, and Evergreen Theragnostics.
Chemicals/Chemical API Manufacturing
Dipharma Updates Expansion of Pilot Plant Dipharma, a CDMO of active...
Catalent has announced that it will begin the first phase of a planned $100-million expansion at its facility in Anagni, Italy to add biologics drug-substance manufacturing.
The initial phase of the expansion will see the installation of two...
The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Daicel Chiral Technologies, SPI Pharma, Idifarma, and LabVantage Solutions.
Chemicals/Chemical API Manufacturing
Daicel Chiral Technologies Opens New Chiral Separation...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Batavia Biosciences and Swissfillon.
Biologics Manufacturing
Batavia Biosciences, RocketVax in Pact for COVID-19 VaccineBatavia Biosciences, a Leiden, the Netherlands-based...
Albany Molecular Research, Inc. (AMRI), a contract research, development and manufacturing organization, has rebranded and changed its name to Curia. Additionally, Curia has agreed to acquire Integrity Bio, a Thousand Oaks, California-based CDMO...
Philip Morris International (PMI), a cigarette and tobacco manufacturing company, has agreed to acquire Vectura Group, a Chippenham, UK-based drug-delivery company, for an enterprise value of £852 million ($1.2 billion).
PMI reached an agreement...
The latest from CDMOs, CMOs, and suppliers featuring AGC Biologics, Recipharm, Thermo Fisher Scientific, LGM Pharma, Purisys, and Hermes Pharma.
Chemicals/Chemical API Manufacturing
Purisys Obtains Additional ISO CertificationsPurisys, an Athens,...
Lonza has completed the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven, two private-equity firms, for an enterprise value of CHF 4.2 billion ($4.5 billion).
Lonza’s Specialty Ingredients business...
The latest from CDMOs, CMOs, and suppliers featuring Lonza, WuXi STA, Catalent, Cytiva, Novasep, Cerobis-Pharma, Almac, Viralgen, CGT Catapult, and Evotec.
Chemicals/Chemicals API Manufacturing
Lonza Investing $22 M To Expand API Labs, Mfg...
Fujifilm Corporation has announced it will invest a 90 billion Yen ($850 million) to expand Fujifilm Diosynth Biotechnologies, its biologics CDMO and subsidiary.
The 90-billion Yen ($850-million) investment will double Fujifilm Diosynth...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Jubilant HollisterStier, BD, and Cryoport.
Biologics Manufacturing
Ocugen, Jubilant HollisterStier Partner for COVID-19 Vaccine MfgOcugen, a Malvern, Pennsylvania-based...
The latest from CDMOs, CMOs, and suppliers featuring Olon, Metrics Contract Services, Solvias, Entegris, Genezen, and Coriolis Pharma.
Chemicals/Chemical API Manufacturing
Olon Completes HPAPI Production Line Olon, a CDMO of active...
The latest from CDMOs, CMOs, and suppliers featuring Yposkesi, Dendreon Pharmaceuticals, Evonik, and Mikart.
Biologics Manufacturing
Yposkesi Starts Construction of Cell, Gene Therpay Mfg Facility Yposkesi, a Corbeil-Essonnes, France-based CDMO...
